InvestSMART

Symbion Health Limited (ASX: SYB) - Share Price

DELISTED - Current share price for SYB : $4.070

SYB General Information +

ASX Code SYB
Website N/A
Industry/Sector Health Care Facilities
Market Cap ($M) n/a
SYB Share Price $4.070
Day High $0.000
Day Low $0.000
Last Close $4.070
SYB Share Price Movement - ( No change )
Prices as at 14:23, 20 Mar 2008
+Security prices are delayed by at least 20 minutes and are indicative only.

Symbion Health Limited (SYB) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Interim 5¢ 100% 3 Mar 2008 1 Apr 2008 - - -
Final 5¢ 100% 18 Sep 2007 28 Sep 2007 - - -
Interim 4.25¢ 100% 2 Mar 2007 30 Mar 2007 - - -

See all dividends from Symbion Health Limited (SYB) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Symbion Health Limited (SYB) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Symbion Health Limited (SYB)
ORDINARY FULLY PAID
Health Care - Suspension from Official Quotation 13 Mar 2008 5:21PM $4.070 $4.070 fallen by 0%
Symbion Health Limited (SYB)
ORDINARY FULLY PAID
Health Care - PRY: Takeover Offer for Symbion Health Limited 13 Mar 2008 1:02PM $4.070 $4.070 fallen by 0%
Symbion Health Limited (SYB)
ORDINARY FULLY PAID
Health Care - Notice of Extension of Offer from PRY 11 Mar 2008 4:55PM $4.060 $4.070 risen by 0.25%
Symbion Health Limited (SYB)
ORDINARY FULLY PAID
Health Care - Fourth Supplementary Bidder`s Statement 7 Mar 2008 5:19PM n/a $4.070 n/a
Symbion Health Limited (SYB)
ORDINARY FULLY PAID
Health Care - PRY: Primary to Acquire 100% of Symbion 6 Mar 2008 10:27AM $4.100 $4.070 fallen by 0.73%
Symbion Health Limited (SYB)
ORDINARY FULLY PAID
Health Care - Notice of Variation Extending Offer Period 21 Feb 2008 1:43PM $4.090 $4.070 fallen by 0.49%

SYB Directors

Name Position Start Date
Dr Edmund Gregory Thomas Bateman Non-Executive Director 26 Feb 2008
Mr Andrew Duff Non-Executive Director 28 Apr 2008
Edmund James Bateman Non-Executive Director 28 Apr 2008

Symbion Health Limited (SYB) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value

See all changes in directors' interest & trades for Symbion Health Limited (SYB) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

SYB Management

Name Position
Rebecca Liatis Additional Company Secretary
Henry Bateman Additional Company Secretary
Timothy (Tim) Paine Company Secretary

SYB Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (SYB). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
129,413,984 (20%) Primary Health Care Limited
56,268,174 (8.70%) Schroder Investment Management Australia Limited
44,000,269 (6.80%) Oz Management, L.L.C
40,081,975 (6.19%) National Australia Bank Limited Group

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.